GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Debt-to-Revenue

Moogene Medi Co (XKRX:322970) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Moogene Medi Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Moogene Medi Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Moogene Medi Co's annualized Revenue for the quarter that ended in . 20 was ₩0.00 Mil.


Moogene Medi Co Debt-to-Revenue Historical Data

The historical data trend for Moogene Medi Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Debt-to-Revenue Chart

Moogene Medi Co Annual Data
Trend
Debt-to-Revenue

Moogene Medi Co Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Moogene Medi Co's Debt-to-Revenue

For the Biotechnology subindustry, Moogene Medi Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moogene Medi Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moogene Medi Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Moogene Medi Co's Debt-to-Revenue falls into.


;
;

Moogene Medi Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Moogene Medi Co's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Moogene Medi Co's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Moogene Medi Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Moogene Medi Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines